Gå direkt till huvudinnehållet

F-Kalprotektin

Senast reviderad:
Sakkunnig:

  1. Waugh, N, Cummins, E, Royle, P, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess 2013: 17; xv-xix, 1–211. PMID: 24286461. PubMed  
  2. Turvill J. High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal disease. Frontline Gastroenterology 2012; 3: 21- 8. PubMed  
  3. SBU Kommenterar 2014-09-04: Bestämning av kalprotektin i feces kan skilja mellan inflammatorisk tarmsjukdom och icke-inflammatoriska tarmbesvär. www.sbu.se  
  4. Sipponon T, Savilathi E, Kolho KL, et al. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2007; 13: 1-7. PubMed  
  5. Roseth A, Fagerhol MK, Wasiluk J, et al. A new calprotectin PoC device correlates with ELISA and separates between endoscopic assessed mucosal healing and active ulcerative colitis. Gastroenterology 2007; 132: A175. Gastroenterology  
  6. Montalto M, Santoro L; Curgliano V, et al. Faecal calprotectin concentrations in untreated celiac patients. Scand J Gastroenterol 2007; 42: 957-61. PubMed  
  7. vonRoon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007; 102: 803-13. PubMed  
  8. Røseth AG, Aadland E, Grzyb K. Normalization of fecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol 2004; 39: 1017-20. PubMed  
  9. Nilsson-Ehle P, Berggren Söderlund M, Theodorsson E et al (red. Laurells Klinisk kemi i praktisk medicin. Lund: Studentlitteratur, 2012.
  • Anders Kallner, docent och f d överläkare, Karolinska universitetslaboratoriet, Karolinska universitetssjukhuset